Platelet reactivity is associated with arterial stiffness in patients after percutaneous coronary intervention treated with dual antiplatelet therapy

被引：0
|
作者：
Siasos, G. [1 ]
Tousoulis, D. [1 ]
Kioufis, S. [1 ]
Oikonomou, E. [1 ]
Zaromitidou, M. [1 ]
Kokkou, E. [1 ]
Mazaris, S. [1 ]
Konsola, T. [1 ]
Vavuranakis, M. [1 ]
Stefanadis, C. [1 ]
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Dept 1, GR-11527 Athens, Greece
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6493
引用
收藏
页码：1167 / 1167
页数：1
相关论文
共 50 条
  • [21] Incidence Predictors Of Discontinued Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention
    Jiang, Jie
    Zheng, Bo
    Zhang, Yan
    Yu, Ronghui
    Huo, Yong
    Hong, Tao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C135 - C135
  • [22] Incidence and Predictors Of Prolonged Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention
    Zheng, Bo
    Jiang, Jie
    Zhang, Yan
    Yu, Ronghui
    Huo, Yong
    Hong, Tao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C134 - C135
  • [23] One vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention
    Tan, Wei Keith
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (17): : 1715 - 1715
  • [24] Antiplatelet Therapy in Low-Platelet-Count Patients After Percutaneous Coronary Intervention for Acute Coronary Syndromes
    Paciullo, Francesco
    Gresele, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [25] Extended Duration Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Peripheral Arterial Disease: A Meta-Analysis
    Ling, Hua
    Andrews, Ebony
    Ombengi, David
    Li, Fang
    CARDIOLOGY RESEARCH, 2018, 9 (03) : 137 - 143
  • [26] Extended duration dual antiplatelet therapy after percutaneous coronary intervention in patients with peripheral arterial disease: a meta-analysis
    Ling, Hua
    Andrews, Ebony
    Ombengi, David
    Brown, Danielle
    PHARMACOTHERAPY, 2017, 37 (12): : E234 - E234
  • [27] prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with or without peripheral arterial disease
    Franzone, A.
    Piccolo, R.
    Gargiulo, G.
    Ariotti, S.
    Marino, M.
    Santucci, A.
    Baldo, A.
    Magnani, G.
    Moschovitis, A.
    Windecker, S.
    Valgimigli, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1030 - 1030
  • [28] Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention
    Tadanao Higaki
    Satoshi Kurisu
    Noriaki Watanabe
    Hiroki Ikenaga
    Takashi Shimonaga
    Toshitaka Iwasaki
    Naoya Mitsuba
    Ken Ishibashi
    Yoshihiro Dohi
    Yukihiro Fukuda
    Yasuki Kihara
    Heart and Vessels, 2016, 31 : 269 - 274
  • [29] Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention (vol 15, pg 797, 2022)
    Redfors, B.
    Kirtane, A. J.
    Liu, M.
    Musikantow, D. R.
    Witzenbichler, B.
    Rinaldi, M. J.
    Metzger, D. C.
    Weisz, G.
    Stuckey, T. D.
    Brodie, B. R.
    Ben-Yehuda, O.
    Mehran, Roxana R.
    Stone, G. W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (19) : 2001 - 2001
  • [30] Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention
    Higaki, Tadanao
    Kurisu, Satoshi
    Watanabe, Noriaki
    Ikenaga, Hiroki
    Shimonaga, Takashi
    Iwasaki, Toshitaka
    Mitsuba, Naoya
    Ishibashi, Ken
    Dohi, Yoshihiro
    Fukuda, Yukihiro
    Kihara, Yasuki
    HEART AND VESSELS, 2016, 31 (03) : 269 - 274
12345